85
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index

, , , , , & show all
Pages 51-62 | Published online: 06 Jan 2010

References

  • NygrenPLarssonROverview of the clinical efficacy of investigational anticancer drugsJ Intern Med20032531467512588538
  • KerwinSMSoy saponins and the anticancer effects of soybeans and soy-based foodsCurr Med Chem Anticancer Agents20044326327215134504
  • RaoAVSungMKSaponins as anticarcinogensJ Nutr19951253 Suppl717S724S7884557
  • TianFZhangXTongYPE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro andin vivoCancer Biol Ther20054887488216082187
  • TinMMChoCHChanKJamesAEKoJKAstragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograftCarcinogenesis20072861347135517148504
  • HwangSJChaJYParkSGDiol- and triol-type ginseng saponins potentiate the apoptosis of NIH3T3 cells exposed to methyl methanesulfonateToxicol Appl Pharmacol2002181319220212079428
  • WangZPSaponins as Anticancer Agent United States Patent 20050175623 A12005
  • KensilCRPatelULennickMMarcianiDSeparation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortexJ Immunol199114624314371987271
  • KerstenGFSpiekstraABeuveryECCrommelinDJOn the structure of immune-stimulating saponin-lipid complexes (iscoms)Biochim Biophys Acta1991106221651712004105
  • RonnbergBFekaduMMoreinBAdjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrixVaccine19951314137513828585296
  • MoreinBHuKLovgrenKD’HondtESinghMANew ISCOMs meet unsettled vaccine demandsVaccine Adjuvants and Delivery SystemsHoboken, NJJohn Wiley & Sons, Inc2007191222
  • LovgrenKMoreinBTheISCOMan antigen delivery system with built-in adjuvantMol Immunol19912832852862017197
  • LovgrenKMoreinBThe ISCOM™ Technology. Vaccin adjuvants: Preparation methods and research protocolsMethods Mol Med200042239258
  • MoreinBSundquistBHoglundSDalsgaardKOsterhausAISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped virusesNature198430859584574606709052
  • DaltonWDurieBAlbertsDGerlachJCressACharacterization of a new drug-resistant human myeloma cell line that expresses p-glycoproteinCancer Res198646512551302875788
  • BellamyWDaltonWGleasonMGroganTTrentJDevelopment and characterization of a melphalan-resistant human multiple myeloma cell lineCancer Res19915199510021988143
  • BotlingJLimingaGLarssonRNygrenPNilssonKDevelopment of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170 kDa p-glycoproteinInt J Cancer1994582692747913083
  • DanksMSchmidtCCirtainMSuttleDBeckWAltered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry198827886188692853972
  • LarssonRKristensenJSandbergCNygrenPLaboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia using a fluorometric microculture cytotoxicity assay (FMCA)Int J Cancer1992501771851730510
  • LovborgHNygrenPLarssonRMultiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828Mol Cancer Ther20043552152615141009
  • HilfRGoldenbergHMichelIOrlandoRAArcherFLEnzymes, nucleic acids, and lipids in human breast cancer and normal breast tissueCancer Res1970306187418824318708
  • PerkinsRGKummerowFAMajor lipid classes in plasma membrane isolated from liver of rats fed a hepatocarcinogenBiochim Biophys Acta197642434694801259971
  • DumitriuIEBaruahPManfrediAABianchiMERovere-QueriniPHMGB1: guiding immunity from withinTrends Immunol200526738138715978523
  • WikmanMFriedmanMPinitkiatisakulSGeneral strategies for efficient adjuvant incorporation of recombinant subunit immunogensVaccine200523171823312335
  • HuKFLovgren-BengtssonKMoreinBImmunostimulating complexes (ISCOMs) for nasal vaccinationAdv Drug Deliv Rev2001511314915911516775